| View |
|
DRP-14970
|
Etoricoxib
|
Coxwel
|
90 mg
|
Film-Coated Tablet
|
Non-steroid Anti-inflammatory and Anti-rheumatic
Product (Coxib)
|
Magbro Healthcare Pvt. Ltd.
|
India
|
Initial
|
28 February 2024
|
28 February 2029
|
| View |
|
DRP-14968
|
Doxofylline
|
Saphfylline
|
400mg
|
Tablet
|
Bronchodilator
|
Sapphire Lifesciences Pvt. Ltd.
|
India
|
Initial
|
28 February 2024
|
28 February 2029
|
| View |
|
DRP-14976
|
Miconazole
|
Rainazole
|
20 mg/g (2% w/w)
|
Cream
|
Antifungal
|
PSA Chemicals and Pharmaceuticals Pvt. Ltd.
|
India
|
Initial
|
05 March 2024
|
05 March 2029
|
| View |
|
DRP-14974
|
Iron Folic Acid + Pyridoxine hydrochloride (Vitamin B6) + Cyanocobalamin (Vitamin B12)
|
Ramerate
|
60 mg (equivalent to 187.5 mg Ferrous Sulfate)/600
mcg/20 mg/25 mcg
|
Film-Coated Tablet
|
Anti-anemia/Vitamins
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
Initial
|
05 March 2024
|
05 March 2029
|
| View |
|
DRP-14975
|
Zinc
|
Zitriol
|
30mg
|
Capsule
|
Mineral
|
Drugmaker's Laboratories, Inc.
|
Philippines
|
Initial
|
05 March 2024
|
05 March 2026
|
| View |
|
DR-XY48855
|
Deferasirox
|
Defrijet 500
|
500 mg
|
Tablet For Oral Suspension
|
Iron chelating agent
|
Sun Pharmaceutical Industries Limited
|
India
|
Monitored Release (Reconstruction)
|
18 April 2024
|
24 August 2028
|
| View |
|
DR-XY48854
|
Irinotecan Hydrochloride Trihydrate
|
Infuirino
|
1.5 mg/mL (270 mg/180 mL), (300 mg/200 mL),
(315 mg/210 mL), (330 mg/220 mL, (360 mg/240 mL)
|
Solution for IV Infusion
|
Antineoplastic [Topoisomerase 1 (TOP 1) inhibitor]
|
Sun Pharmaceutical Industries Limited
|
India
|
Monitored Release (Correction)
|
18 April 2024
|
24 August 2028
|
| View |
|
DRP-14349
|
Deferasirox
|
Defrijet 250
|
250 mg
|
Tablet For Oral Suspension
|
Iron chelating agent
|
Sun Pharmaceutical Industries Limited
|
India
|
Initial (Correction)
|
18 April 2024
|
24 August 2028
|
| View |
|
DRP-14953
|
Diosmin Hesperidin
|
Hemosdin
|
450 mg/50 mg
|
Film-Coated Tablet
|
Vasoprotective (Capillary Stabilizing Agent)
|
Fredun Pharmaceuticals Limited
|
India
|
Initial
|
29 February 2024
|
01 March 2029
|
| View |
|
DRP-14954
|
Fusidic Acid
|
Phudicin
|
20 mg/g (2% w/w)
|
Topical Cream
|
Antibacterial for Topical Use
|
Bright Future Pharmaceuticals Factory O/B Bright
Future Pharmaceutical Laboratories Ltd.
|
Hongkong
|
Initial
|
29 February 2024
|
01 March 2029
|
| View |
|
DRP-13608-01
|
Levocetirizine dihydrochloride
|
Levollen
|
2.5 mg/5 mL
|
Syrup
|
Antihistamine
|
Enicar Pharmaceuticals Pvt. Ltd
|
India
|
CLIDP Conversion
|
26 April 2023
|
17 March 2028
|
| View |
|
DRP-8116-02
|
Silver Sulfadiazone
|
Silvederma
|
10mg/g (1% w/w)
|
Topical Cream
|
Antibacterial (Sulfonamide)
|
S. Kant Healthcare Limited
|
India
|
CLIDP Conversion
|
13 February 2023
|
15 January 2028
|
| View |
|
DRP-8116-05
|
Silver Sulfadiazine
|
Zylfacare
|
10 mg/g (1% w/w)
|
Topical Cream
|
Antibacterial (Sulfonamide)
|
S Kant Healthcare Limited
|
India
|
CLIDP Conversion
|
31 December 2023
|
15 January 2028
|
| View |
|
DRP-11793-01
|
Ketoconazole
|
Ennazole
|
20 mg/g (2% w/w)
|
Cream
|
Antifungal
|
S Kant Healthcare Limited
|
India
|
CLIDP Conversion
|
30 March 2023
|
29 April 2027
|
| View |
|
DRP-11546-02
|
Paracetamol
|
Fleximol
|
10 mg/mL (1g/100 mL)
|
Solution for Injection (IV Infusion)
|
Analgesic/Anti-pyretic (Anilide)
|
Eurolife Healthcare Pvt. Ltd
|
India
|
CLIDP Conversion
|
18 May 2023
|
30 March 2027
|
| View |
|
DRP-11546-04
|
Paracetamol
|
Biodol IV
|
10 mg/ mL (1g/100 mL)
|
Solution for Injection (IV Infusion)
|
Analgesic/Anti-pyretic (Anilide)
|
Eurolife Healthcare Pvt. Ltd
|
India
|
CLIDP Conversion
|
03 October 2023
|
30 March 2027
|
| View |
|
DRP-11546-03
|
Paracetamol
|
Parazar IV
|
10 mg/mL (1 g/ 100 mL)
|
Solution for Injection (IV Infusion)
|
Analgesic/Anti-pyretic (Anilide)
|
EuroLife HealthCare Pvt. Ltd
|
India
|
CLIDP Conversion
|
12 June 2023
|
30 May 2027
|
| View |
|
DRP-11546-01
|
Paracetamol
|
Rextamol
|
10 mg/mL (1g/100 mL)
|
Solution for Injection (IV Infusion)
|
Analgesic/Anti-pyretic (Anilide)
|
Eurolife Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
09 May 2023
|
30 March 2027
|
| View |
|
DRP-10601-01
|
Mupirocin
|
Retaproban
|
20 mg/g (2% w/w)
|
Ointment
|
Antibacterial
|
Zhejiang Jingwei Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
23 May 2023
|
21 October 2026
|
| View |
|
DRP-10324-2
|
Etoricoxib
|
Restorix-60
|
60 mg
|
Film-Coated Tablet
|
Non-Steroidal Anti-inflammatory and Antirheumatic
|
Hiral Labs Limited
|
India
|
CLIDP Conversion
|
23 May 2023
|
10 September 2026
|